3021.htm
Cubex Tubings Share Price
Wed, 12 Mar 2025 17:00:00 GMT
3 Year 221.24% 223.00% 32.90% 34.68% ...
Elevation Oncology Reports Fourth Quarter and Full Year 2024 Financial Results and Highlights Recent Business Achievements
Thu, 06 Mar 2025 05:30:00 GMT
Dosing ongoing in Phase 1 clinical trial cohorts evaluating Claudin 18.2 ADC EO-3021 in combination with ramucirumab or dostarlimab in patients with advanced gastric/gastroesophageal junction (GEJ) ...